In my mind the best way to look at the fairness of the placement and SPP is to consider what would have eventuated had a pro-rate rights issue been undertaken.
About 13.5m new shares will be issued @$3.70 to raise $50m, HSN currently have 182m shares on issue. That means a rights issue of 13.5 shares for every share held would need to have been instituted to raise the $50m under a hypothetical rights issue.
If a shareholder takes up the full $5000 entitlement under the SPP (assuming no scale back), that means a shareholder will end up with about 1350 new shares.
Hence the key shareholding number here is about 18,000 shares. If 18,000 shares is your current holding and there was a 13.5 for 1 rights issue, you would be entitled to about 1350 new shares (ie. exactly what you will get under the $5000 SPP entitlement)!
Those who hold above 18,000 shares are being diluted, those who hold below 18,000 will proportionally increase their holding - assuming a full SPP allocation.
However, since the company has just announced a weaker than expected 2H2017 which has slightly missed consensus forecasts, and considering the Enoro acquisition cost is a pretty generous 10.5 x EBITDA, we might all the get another chance to buy on-market at around the $3.70 mark. Let's also not forget that the share price has been below $3.70 for almost all of this year as an opportunity to top-up for those with conviction about the company.
- Forums
- ASX - By Stock
- HSN
- Ann: Acquisition of Enoro and $50m equity raising
Ann: Acquisition of Enoro and $50m equity raising, page-37
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HSN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$5.52 |
Change
0.070(1.28%) |
Mkt cap ! $1.124B |
Open | High | Low | Value | Volume |
$5.41 | $5.59 | $5.39 | $4.995M | 904.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 29320 | $5.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.53 | 3476 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 29320 | 5.520 |
1 | 6350 | 5.510 |
3 | 5750 | 5.500 |
1 | 2912 | 5.490 |
2 | 6912 | 5.480 |
Price($) | Vol. | No. |
---|---|---|
5.530 | 3476 | 1 |
5.550 | 2912 | 1 |
5.560 | 2912 | 1 |
5.570 | 2912 | 1 |
5.580 | 132 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
HSN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online